Abstract: A conduit management device and method for quickly and easily securing a conduit and reducing the risk of conduit disruption is disclosed. A selectively securable cleat is arranged for selective encirclement and securement of at least a portion of a conduit by wrapping the conduit around the cleat. An embodiment is disclosed having an elongate cleat that is fixed to the patient apparatus at a first location of the cleat spaced apart from releasably securable locations proximate first and second ends of the cleat such that the fixation point at the first location forms the fixed base of the cleat.

Abstract: A guidewire for backloading and inserting a percutaneous pump affixed to a cannula includes a proximal section made of a first material, with a first diameter, a rounded proximal end, and a distal end. The guidewire also includes a distal section made of a second material, with a second diameter which is greater than the first diameter, a distal end, and a proximal end abutting the distal end of the proximal section. The first material of the proximal section is selected to be softer than a material of the percutaneous pump to reduce damage to the pump during backloading. The distal section of the guidewire is configured to be stiffer than the proximal section to insert the percutaneous pump in a desired location without damaging the guidewire.

Abstract: A system for traversing an arterial occlusion in an artery includes a housing sized to fit in a palm of a user, an elongate drive tube configured to be rotated by the housing, the drive tube including an axially extending passage, a cylindrical member, configured to be rotationally coupled to the drive tube, such that a distal tip of the cylindrical member may be delivered to a location adjacent the arterial occlusion when the cylindrical member is coupled to the drive tube, and wherein grasping and activating the housing such that the drive tube is rotated, thereby causes the distal tip of the cylindrical member to be rotated, the rotation of the distal tip including at least a component of linear oscillation.

Abstract: Provided is a coated implantable medical device, comprising: a substrate; and a coating disposed on the substrate, wherein the coating comprises at least one polymer and at least one pharmaceutical agent in a therapeutically desirable morphology and/or at least one active biological agent and optionally, one or more pharmaceutical carrying agents; wherein substantially all of pharmaceutical agent and/or active biological agent remains within the coating and on the substrate until the implantable device is deployed at an intervention site inside the body of a subject and wherein upon deployment of the medical device in the body of the subject a portion of the pharmaceutical agent and/or active biological agent is delivered at the intervention site along with at least a portion of the polymer and/or a at least a portion of the pharmaceutical carrying agents.

Abstract: A cage can be positioned around a medical balloon, such as an angioplasty balloon, to assist in a medical procedure. The cage can include a plurality of strips, each extending between a set of rings including first and second rings. As the balloon expands, the first and second rings move closer together and allow the strips to expand outward. The cage may have wedge dissectors on the strips.

Abstract: [Subjects] To provide a biliary tract drainage tube in which both an external drainage tube and an internal drainage tube can be installed in a single endoscopic procedure. [Method to Solve] A biliary tract drainage tube used to drain a biliary tract is provided with long external drainage tube 2 and internal drainage tube 3 that is provided on the tip of the external drainage tube so as to be separable from the external drainage tube. Both external drainage tube 2 and internal drainage tube 3 are placed in biliary tract Cd. Since internal drainage tube 3 can be left behind in the biliary tract by removing external drainage tube 2, another endoscopic procedure is not required when switching from external drainage tube 2 to internal drainage tube 3, and the burden placed on the patient can be lessened.

Abstract: A set of sinus balloon catheters are provided for treating a patient's paranasal sinus system, including dilating prepared openings, and natural ostia and ducts and excising sinus cavities. These include a balloon catheter with a bend placing a distal segment at 90° to a proximal segment and a balloon catheter which is substantially straight. The catheters have sufficient stiffness and column strength that the balloon carrying distal segment of the catheter can be pushed into the prepared opening, natural ostium or duct, or sinus to be excised. The catheters have appropriate inflated working diameters and appropriate outer diameters with the balloon deflated that will enable the catheter to be pushed into the respective prepared opening, natural ostium or duct, or sinus cavity to be excised. The methods use the balloon catheters to dilate prepared openings to selected parts of the sinus system, to dilate natural ostia and ducts of the sinus system, and/or to dilate sinus cavities to remove them.

Abstract: An expansion device is disclosed, which includes an outer tube in which a plurality of wire portions extending along an axial direction are disposed so as to be arranged in a circumferential direction in the vicinity of a distal portion, and an inner tube that is inserted into the outer tube and is interlocked with the distal portion of the outer tube. The wire portion has an expansion portion which expands radially outward when the outer tube is compressed in the axial direction, a distal side fragile portion which is formed on the distal side of the expansion portion and has flexural rigidity lower than that of the expansion portion, and a proximal side fragile portion which is formed on the proximal side of the expansion portion and having flexural rigidity lower than that of the expansion portion.

Abstract: Disclosed is a microneedle for dental material delivery, the microneedle including a needle body portion; an active ingredient coating portion configured to coat the surface of the needle body portion, and including an active ingredient transferred to the skin tissue within a mouth; and a base portion configured to couple with the needle body portion, and to bend along a skin shape within the mouth, wherein the base portion includes at least one of polyethylene (PE), polypropylene (PP), polytetrafluoroethylene (PTFE), polymethylmethacrylate (PMMA), ethylene vinyl acetate (EVA), polycaprolactone (PCL), polyurethane (PU), polyethylene terephthalate (PET), polyethylene glycol (PEG), polyvinyl alcohol (PVA), poly lactide (PLA), poly lactic-co-glycolic acid (PLGA), and polyglycolide (PGA).

Abstract: The present invention relates to devices and methods for treating, reducing and preventing adverse skin/scalp conditions and enhancing the topical application of a benefit agent. The devices are ultrasonic with transducers positioned at an angle other than 90° relative to the surface at which the ultrasound is to be applied.

Abstract: The present invention relates to devices and methods for treating, reducing and preventing follicular related adverse skin/scalp conditions. The devices are ultrasonic with transducers positioned at an angle other than 90° relative to the surface at which the ultrasound is to be applied.

Abstract: An introducer sheath for percutaneous insertion of a heart pump includes a tubular sheath body having a wall, a proximal end portion, a distal end portion, and an inner lumen. The introducer sheath includes a hemostatic valve disposed in the proximal end portion and forming a liquid tight seal across the inner lumen of the tubular sheath body. The hemostatic valve includes a valve cavity having a distal end and a proximal end, a first annular restriction formed within the valve cavity and having a first diameter, and a second annular restriction formed within the valve cavity distal to the first annular restriction and having a second diameter. The distal end of the valve cavity is spaced from the second annular restriction by a gap distance and a third diameter of the valve cavity along the gap distance is about equal to or greater than the first and second diameters.

Abstract: Hemostasis valves and hemostasis valve assemblies can be coupled to a proximal end of an introducer sheath to prevent blood loss through the proximal end of the introducer sheath. Some hemostasis valve assemblies may include an elastomeric member with a variable-width channel that is designed to form a liquid-tight seal over elongate members of different diameter or a single elongate member of variable diameter.

Abstract: The present invention provides apparatus and methods for making multiple aseptic fluid interconnections in parallel with an integral clamping mechanism and elastomeric fluid sealing gasket to provide an initial fluid tight seal while removing sealing tape tabs and a final fluid tight seal after sealing tape tabs are removed. The clamping mechanism comprises a hinge coupling and a first set of snap-fit locks to maintain the initial fluid tight seal and a second set of snap-fit locks to maintain the final fluid tight seal.

Abstract: A catheter assembly cooperates with a catheter lock enclosure having a base with an entry slot in an end wall. The catheter assembly has a flexible injection line extending from a base and an exterior tube surrounding the injection line and extending from the base. An exterior barrier extends radially outwardly from the exterior tube, and an interior barrier extends radially outwardly from the injection line and is spaced axially along the injection line from the exterior barrier. A gap is defined between the interior barrier and the exterior barrier, which receives the lock enclosure bottom part end wall to restrain the position of the catheter assembly with respect to the lock enclosure, and to restrict access to an interior of the catheter lock enclosure. The exterior tube and the interior and exterior barriers may be formed of high density polyethylene, or hard urethane, or Ultra-high-molecular-weight polyethylene (UHMW).

Abstract: Described is a priming device to prime a gas from a fluid delivery system by receiving the gas and a fluid used to push the gas into a chamber, the priming device including a cover body having a lid, and a housing having a chamber, an inlet port and an opening to release gas received into the chamber. The device has a priming-ready configuration where the medical connector and the housing are coupled with the cover body, and the fluid path of the medical connector and the passage of the housing remain sealed, a priming configuration where the medical connector is advanced in the cover body to fluidly couple with the housing, and a post-priming configuration where the housing is decoupled from the cover body and the lid closed to prevent contamination of the medical connector.

Abstract: A valve arrangement for a medical functional device, wherein the valve arrangement comprises a valve body, which is connected with a separately thereof produced or manufactured cap, wherein the valve body comprises at least one element or spring element, which effects a prestressing or bias of the valve body in the cap.

Abstract: The present invention relates to a medical functional device (900) with a valve seat (803) for a check valve (1), wherein the check valve (1) is embodied such that it takes, in addition to a first position which is suitable for gas sterilization, a second, functional position, by means of applying force onto a section of the check valve (1) and/or by means of moving or shifting the section, in which the check valve adopts a check or non-return function, wherein the check valve (1) is embodied such that it remains in the second position after release or shortfall of the force and/or the moving effect following an accomplished transfer into the second position.

Abstract: An electrode set is disclosed for a defibrillator, the set including at least two electrodes each having a carrier layer, a conductive contact layer, a conductive gel layer, and a non-conductive electrode cover. In the storage state of the electrode set, the electrode covers lie against each other in a planar relationship at least portion-wise, on the side that is remote from the gel layer of the at least two electrodes. The gel layers of the electrodes are directly in contact with each other in a portion-wise manner by way of two openings in the electrode covers.

Abstract: The disclosed wearable device modulates a patient's gastric emptying time and/or gastric retention time. The wearable device includes a microprocessor, electrical stimulator and at least one electrode configured to deliver electrical stimulation to the epidermis, through a range of 0.1 mm to 10 mm or a range of 0.1 mm to 20 mm of the dermis, of a T2 dermatome to a T12 dermatome or meridian of the patient, a C5 to a T1 dermatome across the hand and/or arm, and/or the upper chest regions. The device is adapted to provide electrical stimulation as per stimulation protocols and to communicate wirelessly with a companion control device configured to monitor and record appetite patterns of the patient. The control device is also configured to monitor, record, and modify stimulation parameters of the stimulation protocols.

Abstract: A skin electrode for stimulation comprising a superporous hydrophilic material having a first relaxed state and a second expanded state. In the second expanded state the superporous hydrophilic material is breakable to at least partly enclose at least one hair, and an electrode surface for electrically stimulating the skin by driving current from the electrode surface through the hydrophilic material to the skin comprising the at least one hair.

Abstract: A temporary implantable medical device lead includes a connector, a helically coiled conductor and a first mechanical element. The connector is configured to connect the lead to an external control module. The helically coiled conductor has a proximal end mechanically and electrically connected to the connector. The conductor includes a plurality of filars mechanically and electrically connected to the connector. The first mechanical element includes a metal tube having a plurality of longitudinally spaced grooves formed along an exterior of the tube. The plurality of longitudinally spaced grooves receives at least some of the plurality of filars. The at least some of the plurality of filars electrically connected to the first mechanical element such that the first mechanical element is configured as an electrode to deliver electrical stimulation to portions or systems of a body from the external control module.

Abstract: Described herein are microelectrode array devices, and methods of fabrication, assembly and use of the same, to provide highly localized neural recording and/or neural stimulation to a neurological target. The device includes multiple microelectrode elements arranged protruding shafts. The protruding shafts are enclosed within an elongated probe shaft, and can be expanded from their enclosure. The microelectrode elements, and elongated probe shafts, are dimensioned in order to target small volumes of neurons located within the nervous system, such as in the deep brain region. Beneficially, the probe can be used to quickly identify the location of a neurological target, and remain implanted for long-term monitoring and/or stimulation.

Abstract: An apparatus, including a sterilely sealed package, and an electrode assembly sterilely sealed in the package, wherein the apparatus is configured to enable testing for an open circuit between two electrodes of the electrode assembly with the electrode assembly sterilely sealed in the package.

Abstract: A tip member for inserting into the cochlea, a device comprising: an elongate member including at least one electrode mounted thereon; and a tip member extending distally from a distal end of the elongate member, the tip member comprising a tapered portion tapering distally and a blunt end portion at a distal end of the tapered portion, wherein the tip member is resiliently flexible, and a method for making such a device.

Abstract: An implantable neurostimulation lead comprises a lead body having a distal end and a proximal end, and a lumen extending along a longitudinal axis between the distal and proximal ends. Multiple electrodes are provided proximate to the distal end of the lead body. The electrodes are configured to at least one of deliver stimulating pulses and sense electrical activity. A multi-layer coil is wound about the lumen and extends at least partially along a length of the lead body. The multi-layer coil includes a first winding formed with multiple winding turn segments wound about the lumen in a first direction about the longitudinal axis. The multilayer coil includes a second winding formed with multiple winding turn segments wound about the first winding in an opposite second direction about the longitudinal axis.

Abstract: Methods and apparatus are provided for bilateral renal neuromodulation, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.

Abstract: An implantable stimulation lead is disclosed that includes an elongated lead body having opposed proximal and distal end portions, the lead body being formed from a material having at least one circumferential seal region associated with the distal end portion thereof within which a cylindrical electrode is positioned, the seal region being formed from at least one transition component made from a material that is softer than the material from which the lead body is formed.

Abstract: Disclosed is a method of manufacturing a flexible conductive track arrangement for a neurostimulation system such as a cochlear implant device. The method allows for the arrangement to be manufactured without the need for a transfer substrate by embedding the metal structures of the arrangement in a ceramic dielectric material formed in an atomic layer deposition process, which can be performed at a temperature that is compatible with the polymer processing steps of such an arrangement. A flexible conductive track arrangement and a neurostimulation system are also disclosed.

Abstract: In various examples, an apparatus includes a stimulation lead including an elongate body including a distal end and a proximal end. At least one first electrode is disposed proximate the distal end of the elongate body and is configured to stimulate a first target nerve. At least one second electrode is disposed between the at least one first electrode and the proximal end of the elongate body and is configured to stimulate a second target nerve. At least one first fixation structure is disposed between the at least one second electrode and the proximal end of the elongate body. The at least one first fixation structure is configured to anchor the stimulation lead proximate the sacrum, wherein the at least one first fixation structure is located on the elongate body and spaced a first distance proximally along the elongate body from the at least one first electrode.

Abstract: A system for engaging heart tissue includes an engagement catheter defining a first lumen therethrough and having a suction port at or near a distal end and a vacuum port at or near a proximal end, a delivery catheter defining a delivery catheter lumen therethrough and configured for slidable insertion into the first lumen of the engagement catheter, and an implantable device capable of insertion into the delivery catheter lumen such that at least part of the implantable device extends from a delivery catheter distal end upon implantation into a patient, where the suction port is operable to removably attach to a targeted tissue on an interior wall of a heart of the patient after the engagement catheter has been advanced through a blood vessel and into the heart, thereby forming a reversible seal with the targeted tissue when a vacuum source is operatively coupled to the vacuum port.

Abstract: An apparatus, method and kit are provided for managing a wound in an animal subject. More specifically, an expandable device, which is wound conforming, in direct contact with the wound, and drives wound healing ions into wound tissue, a method for driving wound healing ions into the wound tissue by applying an ionizing current, and a kit for driving wound healing ions into the wound tissue powered by a portable power source are provided. The apparatus, method and kit can be used to increase the penetration of a wound healing agent in the wound tissue, and thus potentially decrease healing time, likelihood of infection, and prevalence of chronic wounds.

Abstract: Provided is a device for iontophoretic delivery of a drug to or into a tissue, including an arrangement that prevents operation of the device at a current density that is higher than a predetermined value, the arrangement including first means responsive to a first data item, indicative of the surface area through which the current is to pass, as to set the maximal current allowed at the surface area indicated by the data item. Also provided is a method for iontophorectivally administering drug to or into a tissue, including determining a maximal allowed level of current density and preventing application of current density above the maximal allowed level.

Abstract: An electroporating drug delivering device using hollow needle electrode includes a drug delivering head, a control console as well as a control line and a tube for connecting the drug delivering head and the control console. The drug delivering head includes a universal joint, a camera, an illuminating lamp, a molecular drug delivery structure, an electric connector, a grille, a hollow needle electrode array, and a stretchable structure. The control console includes a display for observing images, a rocker for controlling the universal joint, and a remote starting unit for controlling the generation of electric pulses. The control console is connected with the electric connector inside of the drug delivering head by the line arranged inside of the tube. The electroporating drug-administration device enhances the drug utilization efficiency and reduces the treatment time, and can accurately adjust the intensity and region of the electric field.

Abstract: An electric pulse generator for electroporator includes a poring pulse generator, and a transfer pulse generator. The poring generator includes an n-stage Cockroft-Walton circuit, and a first circuit branched from a branching point of wiring on output side of the Cockroft-Walton, the first circuit includes a switching switch that is turned off in high-voltage mode and turned on in low-voltage mode, a voltage value for switching between the modes is in 200 to 1400 V, the first circuit includes a second circuit in which m2 series of m1 series-connected capacitors are connected in parallel, the switch and second circuit are connected in series, and first wiring on output side of the second circuit is merged with second wiring on output side of the Cockroft-Walton on output side of the branching point, and a withstand voltage of the Cockroft-Walton is a value in 1500 to 5000 V in the high-voltage mode.

Abstract: A catheter may include electrodes for transvascular nerve stimulation. The electrodes may be positioned within lumens of the catheter and aligned with apertures in the outer wall of the catheter. The electrodes may produce focused electrical fields for stimulation of one or more nerves. In one embodiment, the catheter may include a set of proximal electrodes and a set of distal electrodes, and the proximal electrodes may stimulate a patient's left phrenic nerve and the distal electrodes may stimulate a patient's right phrenic nerve.

Abstract: Sensors are applied to the heart and sensor data is supplied to a rules engine. The rules engine applies rules that reflect a CRM pharmaceutical regime of the patient to the sensor data to determine whether an electrical waveform should be applied to the heart. When electrical stimulation is warranted, the drug “awareness” rules are used by the rules engine to instruct a multi-phase cardiac stimulus generator to generate an electrical waveform that improves the performance of the drugs administered to the patient, allow the patient to be administered a lower dose of a particular drug, and/or reduce or eliminate side effects from the drugs.

Abstract: A system and method for treatment using electrical stimulation is described. The electrical stimulation system includes a platform supporting a plurality of electrical conductor handles and a control module. The handles are rigidly coupled to the platform and extend away from a surface. The control module provides a first method of regulating electrical power between the handles. Adjustment of pressure and surface area contact with a conductive matter provides a secondary method and instantaneous electrical power adjustment. Current is passed through conductive matter between the handles. An optional porous compressible member is used to aid in providing satisfactory contact with the conductive matter.

Abstract: A system includes a cochlear implant (CI) device and a screening device. The CI device includes an electrode array comprising a plurality of stimulation electrodes to be implanted in a patient's cochlea for electrical stimulation of the cochlea, a stimulation signal unit for generating stimulation signals to be supplied to the stimulation electrodes, and a unit for capturing ECAP signals induced at the electrodes in response to stimulation of the cochlea by applying stimulation signals to the electrodes. The screening device is adapted to cooperate with the stimulation signal unit in a manner so as to provide the electrodes with stimulation signals suitable for conducting growth function measurements, recovery measurements and spread-of-excitation measurements.

Abstract: An exemplary system includes 1) a programming device configured to be located external to a cochlear implant patient and communicatively coupled to a cochlear implant system associated with the patient, 2) a programming interface device communicatively coupled to the programming device and configured to be located external to the patient, and 3) a receiver communicatively coupled directly to the programming interface device. The programming device directs at least one of the cochlear implant system and the receiver to apply stimulation to the patient, records an evoked response that occurs in response to the stimulation, and performs a predetermined action in accordance with the evoked response. Corresponding systems and methods are also disclosed.

Abstract: A signal processing arrangement is described for signal processing in a bilateral hearing implant system having left side and right side hearing implants. An interaural coherence analysis module analyzes system input signals to produce an interaural coherence signal output characterizing reverberation-related similarity of the input signals.

Abstract: A signal processing system is described for a bilateral hearing implant system having left side and right side hearing implants. An interaural coherence analysis module receives input signals from each hearing implant including sensing microphone signals and band pass signals, and analyzes the input signals to produce an interaural coherence signal output characterizing reverberation-related similarity of the input signals. A pulse timing and coding module for each hearing implant then processes the band pass signals to develop stimulation timing signals, wherein for one or more selected band pass signals, wherein the processing includes using an envelope gating function developed from the interaural coherence signal.

Abstract: Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for extravascular delivery of pulsed electric fields to achieve such neuromodulation.

Abstract: An embodiment relates to a method for delivering a vagal stimulation therapy to a vagus nerve, including delivering a neural stimulation signal to non-selectively stimulate both afferent axons and efferent axons in the vagus nerve according to a predetermined schedule for the vagal stimulation therapy, and selecting a value for at least one parameter for the predetermined schedule for the vagal stimulation therapy to control the neural stimulation therapy to avoid physiological habituation to the vagal stimulation therapy. The parameter(s) include at least one parameter selected from the group of parameters consisting of a predetermined therapy duration parameter for a predetermined therapy period, and a predetermined intermittent neural stimulation parameter associated with on/off timing for the intermittent neural stimulation parameter.

Abstract: Electrical stimulation therapy is provided to a patient in order to induce a patient sensation. The patient sensation may be selected from a number of patient sensations. A set of therapy parameter values are associated with each of the number of patient sensations. A user interface allows a user to adjust one or more characteristics of the patient sensation.

Abstract: Electrical stimulation therapy is provided to a patient in order to induce a patient sensation. The patient sensation may be selected from a number of patient sensations. A set of therapy parameter values are associated with each of the number of patient sensations. A user interface allows a user to adjust one or more characteristics of the patient sensation.

Abstract: An example of a system may include a processor; and a memory device comprising instructions, which when executed by the processor, cause the processor to access at least one of: patient input, clinician input, or automatic input; use the patient input, clinician input, or automatic input in a search method, the search method designed to evaluate a plurality of candidate neuromodulation parameter sets to identify an optimal neuromodulation parameter set; and program a neuromodulator using the optimal neuromodulation parameter set to stimulate a patient.

Abstract: Systems and methods for controlling blood pressure by controlling atrial pressure and atrial stretch are disclosed. In some embodiments, a stimulation circuit may be configured to deliver a stimulation pulse to at least one cardiac chamber of a heart of a patient, and at least one controller may be configured to execute delivery of one or more stimulation patterns of stimulation pulses to the at least one cardiac chamber, wherein at least one of the stimulation pulses stimulates the heart such that an atrial pressure resulting from atrial contraction of an atrium overlaps in time a passive pressure build-up of the atrium, such that an atrial pressure of the atrium resulting from the stimulation is a combination of the atrial pressure resulting from atrial contraction and the passive pressure build-up and is higher than an atrial pressure of the atrium would be without the stimulation, and such that the blood pressure of the patient is reduced.

Abstract: A device for ambulatory monitoring for suspected bradycardia or QT monitoring with simultaneous external pacing capability is provided. The device monitors the patient for a significant bradycardic episode and/or prolongation of the QT interval. The device provides a monitor having sensing, pacing, recording and transmission capabilities. At least two pacing electrodes are provided with adhesive backing for application to the anterior chest region with one cathode to the region of the cardiac apex and an anode to the region of the right upper sternal cardiac border. If a bradycardic episode is detected or prolongation of the QT is sufficient, then pacemaking energy is provided to the electrodes allowing the patient time to seek medical care without suffering the results of temporary hemodynamic instability that might otherwise be associated with dysrhythmia.

Abstract: Embodiments of the invention are related to medical devices filled with a liquid composition, amongst other things. In an embodiment, the invention includes a hermetically sealed housing defining an interior volume, a component module disposed within the interior volume, the component module comprising a circuit board, the component module displacing a portion of the interior volume. A liquid composition can be disposed within the housing, the liquid composition filling at least 80% of the interior volume not displaced by the component module. Other embodiments are also included herein.